Metabolic Targeting of Cancer Associated Fibroblasts Overcomes T Cell Exclusion and Chemoresistance in Soft-Tissue Sarcomas

The authors characterized the soft-tissue sarcomas microenvironment using murine models with distinct immune composition by scRNA-seq, and identify a subset of cancer-associated fibroblasts (CAFs) they termed glycolytic CAFs.